Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Palmer

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Science Advances|June 2, 2023
Freshwater and anadromous fishing in Ice Age BeringiaBen A Potter, Carrin M Halffman, Holly J McKinney, et al.
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Cancer Research|July 2, 2020
HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast CancerDebarati Banik, Satish Noonepalle, Melissa Hadley, et al.
Scientific Reports|December 21, 2021
Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Scientific Reports|October 11, 2019
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Scientific Reports|April 18, 2019
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Nature Communications|August 8, 2023
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing miceVijayendra Dasari, Lisa K McNeil, Kirrilee Beckett, et al.
Journal for Immunotherapy of Cancer|November 7, 2022
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancerStephanie Gomez, Olivia L Cox, Reddick R Walker, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2024
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanomaSatish Kumar Reddy Noonepalle, Maria Gracia-Hernandez, Nima Aghdam, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Science Advances|June 2, 2023
Freshwater and anadromous fishing in Ice Age BeringiaBen A Potter, Carrin M Halffman, Holly J McKinney, et al.
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Cancer Research|July 2, 2020
HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast CancerDebarati Banik, Satish Noonepalle, Melissa Hadley, et al.
Scientific Reports|December 21, 2021
Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Scientific Reports|October 11, 2019
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Scientific Reports|April 18, 2019
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Nature Communications|August 8, 2023
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing miceVijayendra Dasari, Lisa K McNeil, Kirrilee Beckett, et al.
Journal for Immunotherapy of Cancer|November 7, 2022
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancerStephanie Gomez, Olivia L Cox, Reddick R Walker, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2024
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanomaSatish Kumar Reddy Noonepalle, Maria Gracia-Hernandez, Nima Aghdam, et al.
Pageof 2